• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人A549肺腺癌细胞中PPARγ激活导致终末分化为脂肪细胞并抑制生长。

Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells.

作者信息

Kim Dae-Young, Moon Sun-Ha, Han Jang-Ho, Kim Mi-Jeong, Oh Seong-Ju, Bharti Dinesh, Lee Sung-Ho, Park Jong-Kuen, Rho Gyu-Jin, Jeon Byeong-Gyun

机构信息

Department of Biology Education, Gyeongsang National University, Jinju, Republic of Korea.

OBS/Theriogenology and Biotechnology, Gyeongsang National University, Jinju, Republic of Korea.

出版信息

Anim Cells Syst (Seoul). 2020 Dec 2;24(6):329-340. doi: 10.1080/19768354.2020.1847731.

DOI:10.1080/19768354.2020.1847731
PMID:33456717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7781920/
Abstract

The present study investigated the terminal differentiation capacity into adipocytes and subsequent growth inhibition in A549 cancer cells treated with pioglitazone (PGZ), a PPARγ activator. The rate of cell growth in A549 cells was significantly (< .05) inhibited in concentrations above 10 μM PGZ while maintaining less cytotoxic effects in MRC-5 fibroblasts. Following 50 μM PGZ treatment, population doubling time (PDT) was significantly ( < .05) increased by inhibition of cell growth, as per increasing PGZ exposure time by up to 4 weeks. The adiposome-like vesicles were commonly observed in the PGZ-treated A549 cells, and the vesicles were highly stained with Oil-Red O solution. In addition, the cell size and expression of GLUT4 and PPARγ were significantly ( < .05) increased, as per increasing PGZ exposure time by up to 4 weeks. The significant ( < .05) down-regulation of telomerase activity and up-regulation of senescence-associated β-galactosidase (SA β-GAL) activity was displayed in the PGZ-treated A549 cells, as per increasing PGZ exposure time by up to 4 weeks. The G1 phase of the cell cycle was also significantly ( < .05) increased in the PGZ-treated A549 cells compared with untreated A549 cells. The present results have demonstrated that activation of PPARγ using PGZ induces cellular differentiation into adipocytes and inhibits cell growth in the A549 cancer cells. The terminal differentiation into adipocytes could offer potent chemotherapy in the cancer cells showing high glucose metabolism.

摘要

本研究调查了用吡格列酮(PGZ,一种PPARγ激活剂)处理的A549癌细胞向脂肪细胞的终末分化能力及随后的生长抑制情况。当PGZ浓度高于10 μM时,A549细胞的生长速率受到显著抑制(<0.05),而对MRC-5成纤维细胞的细胞毒性作用较小。在50 μM PGZ处理后,随着PGZ暴露时间延长至4周,细胞生长受到抑制,群体倍增时间(PDT)显著增加(<0.05)。在经PGZ处理的A549细胞中常见脂滴样小泡,这些小泡被油红O溶液高度染色。此外,随着PGZ暴露时间延长至4周,细胞大小以及GLUT4和PPARγ的表达显著增加(<0.05)。随着PGZ暴露时间延长至4周,经PGZ处理的A549细胞中端粒酶活性显著下调(<0.05),衰老相关β-半乳糖苷酶(SA β-GAL)活性上调。与未处理的A549细胞相比,经PGZ处理的A549细胞的细胞周期G1期也显著增加(<0.05)。目前的结果表明,使用PGZ激活PPARγ可诱导A549癌细胞向脂肪细胞分化并抑制其生长。向脂肪细胞的终末分化可为显示高糖代谢的癌细胞提供有效的化疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/aacc7a3f1cc9/TACS_A_1847731_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/86e99eef91a5/TACS_A_1847731_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/c1599ded974a/TACS_A_1847731_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/0bdeb95e1120/TACS_A_1847731_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/aac034c59cf2/TACS_A_1847731_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/a85c59c4fcac/TACS_A_1847731_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/aacc7a3f1cc9/TACS_A_1847731_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/86e99eef91a5/TACS_A_1847731_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/c1599ded974a/TACS_A_1847731_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/0bdeb95e1120/TACS_A_1847731_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/aac034c59cf2/TACS_A_1847731_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/a85c59c4fcac/TACS_A_1847731_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/7781920/aacc7a3f1cc9/TACS_A_1847731_F0006_OC.jpg

相似文献

1
Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells.人A549肺腺癌细胞中PPARγ激活导致终末分化为脂肪细胞并抑制生长。
Anim Cells Syst (Seoul). 2020 Dec 2;24(6):329-340. doi: 10.1080/19768354.2020.1847731.
2
Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines.在地塞米松敏感的癌细胞系中,细胞分化为脂肪细胞样细胞对细胞生长的抑制作用。
Anim Cells Syst (Seoul). 2018 Jun 18;22(3):178-188. doi: 10.1080/19768354.2018.1476408. eCollection 2018.
3
Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis.吡格列酮,一种过氧化物酶体增殖物激活受体γ配体,可抑制博来霉素诱导的急性肺损伤和肺纤维化。
Respiration. 2009;77(3):311-9. doi: 10.1159/000168676. Epub 2008 Oct 31.
4
Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.吡格列酮可预防吸烟致癌物诱导的小鼠肺部肿瘤发生。
Curr Cancer Drug Targets. 2012 Jul;12(6):597-606. doi: 10.2174/156800912801784848.
5
Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.PPARγ和RAR的配体可诱导人胶质母细胞瘤的生长抑制和凋亡。
J Neurooncol. 2003 Nov;65(2):107-18. doi: 10.1023/b:neon.0000003728.80052.a8.
6
Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats.过氧化物酶体增殖物激活受体 γ 激动剂激活信号转导子和转录激活子 3 有助于去卵巢大鼠缺血后梗死周边区的神经保护。
Stroke. 2012 Feb;43(2):478-83. doi: 10.1161/STROKEAHA.111.618926. Epub 2011 Nov 10.
7
Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.吡格列酮是过氧化物酶体增殖物激活受体γ的配体,可作为结肠癌肝转移的抑制剂。
Anticancer Res. 2008 Nov-Dec;28(6A):3593-9.
8
Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.吡格列酮,一种过氧化物酶体增殖物激活受体γ(PPARγ)激动剂,通过阻断晚期糖基化终末产物(RAGE)信号传导来抑制人肝细胞癌的生长和侵袭。
Mol Carcinog. 2015 Dec;54(12):1584-95. doi: 10.1002/mc.22231. Epub 2014 Oct 12.
9
MK886 inhibits the pioglitazone-induced anti-invasion of MDA-MB-231 cells is associated with PPARα/γ, FGF4 and 5LOX.MK886抑制吡格列酮诱导的MDA-MB-231细胞抗侵袭作用与PPARα/γ、FGF4和5-脂氧合酶有关。
Cytotechnology. 2016 Oct;68(5):1771-87. doi: 10.1007/s10616-015-9930-5. Epub 2016 Jan 11.
10
PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling via RGS4 Signaling in Mouse Model.过氧化物酶体增殖物激活受体 γ 激动剂 PGZ 通过 RGS4 信号减轻卵清蛋白诱导的小鼠气道炎症和气道重塑。
Inflammation. 2018 Dec;41(6):2079-2089. doi: 10.1007/s10753-018-0851-2.

引用本文的文献

1
Targeted Cancer Therapy with Gold-Iron Oxide Nanourchins: Inducing Oxidative Stress, Paraptosis, and Sensitizing Tumor Cells to Cisplatin.金-氧化铁纳米urchin靶向癌症治疗:诱导氧化应激、副凋亡并使肿瘤细胞对顺铂敏感化
Antioxidants (Basel). 2025 Mar 31;14(4):422. doi: 10.3390/antiox14040422.
2
Marine polychaete sp. extracts enhance proliferation and regeneration of mice 3T3 fibroblast and MCR-5 human fibroblast cells.海洋多毛纲动物提取物可促进小鼠3T3成纤维细胞和MCR-5人成纤维细胞的增殖与再生。
Saudi J Biol Sci. 2024 Jan;31(1):103883. doi: 10.1016/j.sjbs.2023.103883. Epub 2023 Nov 25.
3
Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases.

本文引用的文献

1
Epigenetic alterations in cancer.癌症中的表观遗传改变。
Front Biosci (Landmark Ed). 2020 Mar 1;25(6):1058-1109. doi: 10.2741/4847.
2
Adipose cell size changes are associated with a drastic actin remodeling.脂肪细胞大小的变化与剧烈的肌动蛋白重构有关。
Sci Rep. 2019 Sep 10;9(1):12941. doi: 10.1038/s41598-019-49418-0.
3
Telomeres, Telomerase and Ageing.端粒、端粒酶与衰老
人类内源性逆转录病毒作为基因表达调控因子:来自动物模型的人类疾病研究进展。
Mol Cells. 2021 Dec 31;44(12):861-878. doi: 10.14348/molcells.2021.5016.
Subcell Biochem. 2018;90:221-308. doi: 10.1007/978-981-13-2835-0_9.
4
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review).从化疗到生物疗法:减少全身癌症治疗副作用的新概念综述(综述)。
Int J Oncol. 2019 Feb;54(2):407-419. doi: 10.3892/ijo.2018.4661. Epub 2018 Dec 10.
5
Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines.在地塞米松敏感的癌细胞系中,细胞分化为脂肪细胞样细胞对细胞生长的抑制作用。
Anim Cells Syst (Seoul). 2018 Jun 18;22(3):178-188. doi: 10.1080/19768354.2018.1476408. eCollection 2018.
6
Induction of telomere shortening and cellular apoptosis by sodium meta-arsenite in human cancer cell lines.偏亚砷酸钠诱导人癌细胞系端粒缩短及细胞凋亡
Anim Cells Syst (Seoul). 2017 Jul 1;21(4):241-254. doi: 10.1080/19768354.2017.1342691. eCollection 2017.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.当前化疗药物和天然药物治疗非小细胞肺癌效果的综述
Biomedicine (Taipei). 2017 Dec;7(4):23. doi: 10.1051/bmdcn/2017070423. Epub 2017 Nov 13.
9
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.CTLA-4与PD-1通路:它们抑制作用的相似性、差异及意义
Am J Clin Oncol. 2016 Feb;39(1):98-106. doi: 10.1097/COC.0000000000000239.
10
Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line.地塞米松对MCF-7乳腺癌细胞系的抗增殖作用。
Mol Med Rep. 2015 Sep;12(3):4051-4054. doi: 10.3892/mmr.2015.3920. Epub 2015 Jun 12.